- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical vaccine development for H5N1 influenza
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 12, Issue 7, Pages 767-777
Publisher
Informa UK Limited
Online
2013-07-26
DOI
10.1586/14760584.2013.811178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Signaling of MyD88 and TRIF Is Critical for Maximal TLR4-Induced Dendritic Cell Maturation
- (2014) H. Shen et al. JOURNAL OF IMMUNOLOGY
- Association between H1N1 vaccination and narcolepsy-cataplexy: Flu to sleep
- (2013) S. V. Kothare et al. NEUROLOGY
- Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells
- (2013) A. S. McKee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New Strategies for the Development of H5N1 Subtype Influenza Vaccines
- (2012) John Steel BIODRUGS
- Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability
- (2012) Elena Feshchenko et al. BMC BIOTECHNOLOGY
- A Comparative Study of Stress-mediated Immunological Functions with the Adjuvanticity of Alum
- (2012) Yufei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases
- (2012) A. Baz Morelli et al. JOURNAL OF MEDICAL MICROBIOLOGY
- AF03, An Alternative Squalene Emulsion‐Based Vaccine Adjuvant Prepared by a Phase Inversion Temperature Method
- (2012) Marie‐Françoise Klucker et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Adjuvant solution for pandemic influenza vaccine production
- (2012) C. H. Clegg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
- (2012) S. Herfst et al. SCIENCE
- Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections
- (2012) Ge Liu et al. VACCINE
- Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
- (2012) David N. Taylor et al. VACCINE
- The mechanism of action of MF59 – An innately attractive adjuvant formulation
- (2012) D.T. O’Hagan et al. VACCINE
- The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
- (2012) Leonoor Wijnans et al. VACCINE
- Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults
- (2012) Jessica Chichester et al. Viruses-Basel
- Overview of global regulatory toxicology requirements for vaccines and adjuvants
- (2012) Yuansheng Sun et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses
- (2011) Jiri Beran et al. CLINICAL THERAPEUTICS
- A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
- (2011) Richard Fritz et al. JOURNAL OF INFECTIOUS DISEASES
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
- (2011) Hayedeh Behzad et al. JOURNAL OF INFECTIOUS DISEASES
- Hallmarks of CD4 T cell immunity against influenza
- (2011) K. K. McKinstry et al. JOURNAL OF INTERNAL MEDICINE
- H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans
- (2011) S. Khurana et al. JOURNAL OF VIROLOGY
- Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
- (2011) Tracy L Flach et al. NATURE MEDICINE
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- Assessing the Safety of Adjuvanted Vaccines
- (2011) S. S. Ahmed et al. Science Translational Medicine
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17–18 February 2011
- (2011) Marc P. Girard et al. VACCINE
- H5N1 Avian Influenza: Preventive and Therapeutic Strategies Against a Pandemic
- (2010) Suryaprakash Sambhara et al. Annual Review of Medicine
- Use of defined TLR ligands as adjuvants within human vaccines
- (2010) Malcolm S. Duthie et al. IMMUNOLOGICAL REVIEWS
- Influenza vaccine immunology
- (2010) Philip R. Dormitzer et al. IMMUNOLOGICAL REVIEWS
- Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunity in Ferrets
- (2010) S. Khurana et al. JOURNAL OF VIROLOGY
- Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence
- (2010) T. Vesikari et al. PEDIATRICS
- The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza
- (2010) Marc-André D’Aoust et al. PLANT BIOTECHNOLOGY JOURNAL
- A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
- (2010) Rhea N. Coler et al. PLoS One
- Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
- (2010) Nathalie Landry et al. PLoS One
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Vaccination, squalene and anti-squalene antibodies: Facts or fiction?
- (2009) Giuseppe Lippi et al. European Journal of Internal Medicine
- Evaluation of Vaccines for H5N1 Influenza Virus in Ferrets Reveals the Potential for Protective Single-Shot Immunization
- (2009) D. Middleton et al. JOURNAL OF VIROLOGY
- MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
- (2009) Angelika Banzhoff et al. PLoS One
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B cells and aging: molecules and mechanisms
- (2009) Michael P. Cancro et al. TRENDS IN IMMUNOLOGY
- Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
- (2009) Tino F. Schwarz et al. VACCINE
- Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
- (2009) Susan L. Baldwin et al. VACCINE
- MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
- (2009) Michele Pellegrini et al. VACCINE
- Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
- (2009) Isabel Leroux-Roels et al. VACCINE
- The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus
- (2009) Amorsolo L. Suguitan et al. VIROLOGY
- An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults
- (2008) Karin Levie et al. JOURNAL OF INFECTIOUS DISEASES
- Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
- (2008) David I. Bernstein et al. JOURNAL OF INFECTIOUS DISEASES
- Hydrophobic Inactivation of Influenza Viruses Confers Preservation of Viral Structure with Enhanced Immunogenicity
- (2008) Y. Raviv et al. JOURNAL OF VIROLOGY
- Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
- (2008) Isabel Leroux-Roels et al. PLoS One
- Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
- (2008) Rick A. Bright et al. PLoS One
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
- H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses
- (2008) Kutubuddin Mahmood et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation